Genomictree Market Cap

Genomictree has a market cap or net worth of 411.56 billion as of April 10, 2026. Its market cap has decreased by -7.87% in one year.

Market Cap

411.56B

Enterprise Value

336.80B

Revenue

3.76B

Ranking

n/a

PE Ratio

n/a

Stock Price

16,960.00

Market Cap Chart

Since April 5, 2017, Genomictree's market cap has increased from 59.00B to 411.56B, an increase of 597.57%. That is a compound annual growth rate of 24.04%.

Market Cap History

Date	Market Cap	% Change
Apr 9, 2026	406.71B	-38.32%
Dec 30, 2025	659.41B	34.41%
Dec 30, 2024	490.60B	0.78%
Dec 28, 2023	486.82B	168.25%
Dec 29, 2022	181.48B	-32.87%
Dec 30, 2021	270.36B	-7.66%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Apr 5, 2017	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Medy-Tox	666.66B
Proteina	632.30B
Green Cross Holdings	619.73B
SillaJen	530.42B
Helixmith	433.76B
Anterogen.Co.,Ltd.	401.24B
BINEX	358.29B
GC Cell	347.13B

Market Cap Rankings